bronchitis%20-%20chronic%20in%20acute%20exacerbation
BRONCHITIS - CHRONIC IN ACUTE EXACERBATION

Chronic bronchitis is an infection of the trachea and bronchi for at least 3 consecutive months for more than 2 consecutive years.
The patient experiences symptoms of increase in dyspnea, sputum volume and sputum purulence over baseline on most days.

Diagnosis is basically based on clinical presentation.

Bronchitis%20-%20chronic%20in%20acute%20exacerbation Management

Prevention

Influenza Vaccine

  • The use of an annual influenza vaccine for all patients with chronic bronchitis is strongly recommended
    • Patients with chronic lung disease have a higher risk of complications from influenza infection
    • Annual influenza vaccination decreases the morbidity and mortality of influenza in the elderly by 50%
  • Please see Influenza disease management chart for further information

Pneumococcal Vaccine

  • It is recommended that pneumococcal vaccine be administered at least once to patients with chronic bronchitis
    • Consider repeating vaccine every 5-10 years in high-risk patients
  • Pneumococcal vaccine is safe and may reduce invasive pneumococcal infection in patients with COPD
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 Jan 2021
Diagnosis of heart diseases has abruptly and significantly decreased across the globe due to the coronavirus disease 2019 (COVID-19) pandemic, especially affecting poorer countries, reveals a study.
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.

Pearl Toh, Yesterday
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.